Detalles de la búsqueda
1.
Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.
J Neurooncol
; 138(3): 489-498, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29564747
2.
A combination of two antibodies recognizing non-overlapping epitopes of HER2 induces kinase activity-dependent internalization of HER2.
J Cell Mol Med
; 20(10): 1999-2011, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27469139
3.
Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.
MAbs
; 11(4): 666-680, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31046547
4.
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 4(4): e175245, 2018 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29423521
5.
Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms.
Mol Cancer Ther
; 16(12): 2780-2791, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28802255
Resultados
1 -
5
de 5
1
Próxima >
>>